Pediatric Sepsis - Early Recognition, Fluids, and Vasoactive Support

Key Points

• Pediatric septic shock can be present before hypotension develops.
• Do not delay antibiotics in a child with septic shock while waiting for imaging or a perfect diagnostic score.
• Use small, reassessed crystalloid boluses rather than automatic large-volume fluid administration.
• Stop fluid escalation when signs of overload or poor tolerance develop.
• Epinephrine or norepinephrine should be started early when perfusion remains inadequate or more fluid is unsafe.
• Peripheral or IO vasoactive infusion is acceptable temporarily when central access would delay therapy.
• Source control and antimicrobial de-escalation are essential parts of sepsis treatment.

Algorithm

1. Recognize suspected infection plus abnormal perfusion or organ dysfunction and activate the pediatric sepsis pathway.
2. Obtain cultures and focused tests without delaying resuscitation or antibiotics.
3. Give empiric antimicrobials promptly, tailored to age, source, host risk, and local resistance.
4. Provide 10 to 20 mL/kg crystalloid boluses when shock is present, reassessing after each bolus.
5. Start epinephrine or norepinephrine if shock persists or further fluid appears unsafe.
6. Support oxygenation, ventilation, glucose, electrolytes, renal function, coagulation, and temperature according to organ dysfunction.
7. Pursue urgent source control and narrow antimicrobials as data become available.
8. Escalate refractory shock or hypoxemia to PICU and ECMO-capable care when appropriate.

Clinical Synopsis & Reasoning

Pediatric sepsis presents differently across age groups and often before hypotension develops. Tachycardia, altered mental status, delayed or flash capillary refill, temperature abnormality, weak or bounding pulses, oliguria, respiratory distress, and cool or mottled skin can be early manifestations. The 2024 Phoenix criteria provide contemporary diagnostic criteria for sepsis in children with suspected infection, but a bedside clinician should not wait for a formal score before treating a child who is clearly developing shock or organ dysfunction. Sepsis and septic shock are syndromes, not single laboratory diagnoses.

Identify the likely source and host risk. Pneumonia, bloodstream infection, urinary infection, meningitis, abdominal infection, skin and soft-tissue infection, and device-related infection are common. Young infants, immunocompromised children, children with complex medical devices, and those with sickle cell disease or functional asplenia need broader consideration of pathogens. Obtain blood cultures before antibiotics when feasible without delaying therapy. Source-specific cultures, imaging, and lumbar puncture should be timed according to stability. A child in shock should not wait for CT or lumbar puncture before antimicrobials and resuscitation.

Perfusion assessment must be repeated after every intervention. Lactate can support recognition of impaired oxygen delivery and can trend with treatment, but normal lactate does not exclude septic shock. Bedside ultrasound may help evaluate ventricular function, volume tolerance, and alternative causes of shock, especially when repeated fluids are being considered. Warm and cold shock phenotypes are not perfectly reliable for selecting a vasoactive drug, so current management emphasizes the overall hemodynamic picture and response rather than rigid phenotype labels.

Treatment Strategy & Disposition

Establish vascular access quickly, using intraosseous access if IV placement would delay resuscitation. Give empiric antibiotics as soon as possible. Current Surviving Sepsis Campaign guidance continues to prioritize very early antimicrobials in septic shock, with the regimen selected for age, source, comorbidities, prior resistant organisms, and local susceptibility patterns. Narrow therapy when microbiology and the clinical course permit. Source control, such as drainage of abscess, removal of an infected device, or surgery for perforation, is part of definitive therapy.

Fluid resuscitation is individualized. In settings with intensive care capability, children with septic shock may receive 10 to 20 mL/kg crystalloid boluses with frequent reassessment, generally up to an initial cumulative volume while watching for improvement or fluid overload. Stop or slow boluses when pulmonary edema, hepatomegaly, worsening oxygenation, or other signs of intolerance appear. Balanced crystalloids are reasonable. The goal is restoration of perfusion, not reaching a predetermined fluid total. Children with severe malnutrition, cardiac disease, renal failure, or resource-limited settings require modified strategies.

Start vasoactive support early when shock persists after initial fluid or when additional fluid is likely to be harmful. Epinephrine and norepinephrine are preferred first-line vasoactive infusions over dopamine in contemporary pediatric sepsis care. They can be started through a well-functioning peripheral IV or IO while central access is obtained, with close site monitoring. Provide oxygen and respiratory support, correct hypoglycemia, treat seizures, and support renal and hematologic dysfunction. Routine corticosteroids are not recommended for every child, but stress-dose hydrocortisone is appropriate for suspected or documented adrenal insufficiency; evidence is insufficient for routine hydrocortisone solely because shock remains unstable. Refractory shock or hypoxemia warrants early PICU escalation and consideration of ECMO in selected centers.

Epidemiology / Risk Factors

• Sepsis remains an important cause of pediatric morbidity and mortality worldwide.
• Infants, immunocompromised children, and children with chronic complex disease carry increased risk.
• The epidemiology and resistant organisms vary substantially by hospital and region.
• Survival has improved with structured recognition and resuscitation, but delayed recognition remains a major contributor to poor outcome.

Investigations

Signs of Poor Perfusion

Pharmacology

Prognosis / Complications

• Outcome depends on illness severity, timeliness of antibiotics and hemodynamic support, underlying disease, and source control.
• Persistent hyperlactatemia, multiple organ dysfunction, refractory shock, and severe neurologic injury are adverse prognostic features.
• Fluid overload during critical illness is associated with worse respiratory and renal outcomes.
• Children who survive severe sepsis may have physical, neurocognitive, and psychological sequelae that require follow-up.

Patient Education / Counseling

• Explain to families that treatment often begins before the exact organism is known because delay can be dangerous.
• Discuss why fluids are reassessed after each bolus rather than automatically continued.
• When a device or surgical source is suspected, explain that antibiotics alone may not cure the infection without source control.
• After recovery, review vaccination, device care, sickle-cell fever plans, or immunocompromise-specific prevention when relevant.
• Families of sepsis survivors should be told to seek follow-up for new weakness, sleep problems, school difficulties, anxiety, or other post-intensive-care symptoms.

Notes

The 2026 pediatric Surviving Sepsis Campaign reinforces a targeted approach rather than a ritualized sequence of large fluid volumes. A 20 mL/kg bolus can be lifesaving in a fluid-responsive child, but the same bolus can worsen respiratory failure in a child with myocardial dysfunction or emerging overload. Reassessment after each intervention is therefore part of the treatment itself.

Sepsis care also extends beyond the first hour. Culture results, source control, fluid balance, ventilation, renal support, nutrition, and antimicrobial stewardship determine the rest of the trajectory. Once shock stabilizes, preventing unnecessary fluid accumulation and narrowing antibiotics are active treatment decisions, not afterthoughts.

References

1. Society of Critical Care Medicine: 2026 Surviving Sepsis Campaign Pediatric Guidelines — Link
2. Society of Critical Care Medicine: Phoenix pediatric sepsis definitions — Link